UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance

Blood, 2000-08, Vol.96 (3), p.1070-1079

2000

Volltextzugriff (PDF)

p62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells

Cell death and differentiation, 2014-12, Vol.21 (12), p.1852-1861

2014

Volltextzugriff (PDF)

Leucémie myéloïde chronique : application à la clinique de la thérapie cellulaire et génique

Hematology and cell therapy (Print), 1998, Vol.40 (5), p.247-250

REIFFERS, J

1998

Volltextzugriff (PDF)

Follow-Up of Complete Cytogenetic Remission in Patients With Chronic Myeloid Leukemia After Cessation of Interferon Alfa

Journal of clinical oncology, 2002-01, Vol.20 (1), p.214-220

Mahon, F. X.

2002

Volltextzugriff (PDF)

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres

British journal of haematology, 2001-04, Vol.113 (1), p.209-216

2001

Volltextzugriff (PDF)

On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia

Leukemia, 2008-09, Vol.22 (9), p.1707-1711

2008

Volltextzugriff (PDF)

Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia

Leukemia, 1997-11, Vol.11 (11), p.1878-1886

1997

Volltextzugriff (PDF)

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

Leukemia, 2003-05, Vol.17 (5), p.869-875

2003

Volltextzugriff (PDF)

Allogeneic Bone Marrow Transplantation in Multiple Myeloma

The New England journal of medicine, 1991-10, Vol.325 (18), p.1267-1273

1991

Volltextzugriff (PDF)

Leucémie myéloïde chronique : étude critique des essais thérapeutiques de l'interféron-alpha recombinant et analyse des facteurs de pronostic

Hématologie, 1999, Vol.5 (3), p.225-232

1999

Volltextzugriff (PDF)

Intérêt du dosage sérique de l'antigène galactomannane par méthode ELISA chez les patients présentant un risque d'aspergillose invasive dans un service d'hématologie

Journal de mycologie médicale, 2002-09, Vol.12 (3), p.131-135

2002

Volltextzugriff (PDF)

Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle

Journal of clinical oncology, 1997-06, Vol.15 (6), p.2238-2246

1997

Volltextzugriff (PDF)

R2: Rôle de l’autophagie dans la sensibilité des lignées de liposarcome à un nouvel agent anti-tumoral : l’Aplidine

Bulletin du cancer, 2010-10, Vol.97 (4), p.S17-S18

2010

Volltextzugriff (PDF)

Proteasome inhibitIon specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteins

Cancer biology & therapy, 2007-04, Vol.6 (4), p.603-611

2007

Volltextzugriff (PDF)

Electrical characterization of different DEPFET designs on die level

Journal of instrumentation, 2014-01, Vol.9 (1), p.C01020-C01020, Article C01020

2014

Volltextzugriff (PDF)

Mécanismes moléculaires contrôlant le cycle cellulaire : aspects fondamentaux et implications en cancérologie

Cancer radiothérapie, 2001-04, Vol.5 (2), p.109-129

2001

Volltextzugriff (PDF)

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

The New England journal of medicine, 2010-06, Vol.362 (24), p.2251-2259

2010

Volltextzugriff (PDF)

Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph‐positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study

American journal of hematology, 2010-03, Vol.85 (3), p.164-170

2010

Volltextzugriff (PDF)

Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM)

British journal of haematology, 1997-06, Vol.97 (4), p.865-870

1997

Volltextzugriff (PDF)

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Leukemia, 2009-06, Vol.23 (6), p.1054-1061

2009

Volltextzugriff (PDF)

Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase : A report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 1997-10, Vol.20 (7), p.553-560

1997

Volltextzugriff (PDF)

Karyotype in acute myeloblastic leukemia : Prognostic significance for bone marrow transplantation in first remission : A european group for blood and marrow transplantation study

Blood, 1997-10, Vol.90 (8), p.2931-2938

1997

Volltextzugriff (PDF)

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

Blood, 2003-03, Vol.101 (6), p.2368-2373

2003

Volltextzugriff (PDF)

1 – 25 von 821

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(668)
Mit Volltextzugriff
(563)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(448)
Science & Technology
(405)
Life Sciences & Biomedicine
(341)
Male
(262)
Female
(254)
Adult
(238)
Biological And Medical Sciences
(237)
Middle Aged
(226)
Hematology
(220)
Medical Sciences
(219)
Oncology
(152)
Adolescent
(135)
Aged
(126)
Bone Marrow Transplantation
(102)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(85)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(82)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(82)
Child
(70)
Pharmacology. Drug Treatments
(68)
Treatment Outcome
(66)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance

p62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study

Leucémie myéloïde chronique : application à la clinique de la thérapie cellulaire et génique

Follow-Up of Complete Cytogenetic Remission in Patients With Chronic Myeloid Leukemia After Cessation of Interferon Alfa

Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres

On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia

Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment

Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

Allogeneic Bone Marrow Transplantation in Multiple Myeloma

Leucémie myéloïde chronique : étude critique des essais thérapeutiques de l'interféron-alpha recombinant et analyse des facteurs de pronostic

Intérêt du dosage sérique de l'antigène galactomannane par méthode ELISA chez les patients présentant un risque d'aspergillose invasive dans un service d'hématologie

Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle

R2: Rôle de l’autophagie dans la sensibilité des lignées de liposarcome à un nouvel agent anti-tumoral : l’Aplidine

Proteasome inhibitIon specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteins

Electrical characterization of different DEPFET designs on die level

Mécanismes moléculaires contrôlant le cycle cellulaire : aspects fondamentaux et implications en cancérologie

Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

Dasatinib 140 mg once daily versus 70 mg twice daily in patients with Ph‐positive acute lymphoblastic leukemia who failed imatinib: Results from a phase 3 study

Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM)

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase : A report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Karyotype in acute myeloblastic leukemia : Prognostic significance for bone marrow transplantation in first remission : A european group for blood and marrow transplantation study

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

Suchergebnisse filtern